---
title: DDR is Now Veristat
description: DDR Drug Development & Regulation is now part of the Veristat global regulatory team, offering bold thinking and scientific-minded regulatory expertise to ensure the successful navigation of regulatory requirements.
---

[![Veristat_logo_tm](https://www.veristat.com/hs-fs/hubfs/Veristat_logo_tm.png?width=500&height=121&name=Veristat_logo_tm.png "Veristat_logo_tm")](https://www.veristat.com)

## DDR is Now Veristat

# Bold thinking to tackle any regulatory problem

DDR Drug Development & Regulation is now part of the Veristat global regulatory team.   Offering bold thinking and scientific-minded regulatory expertise to ensure the successful navigation of regulatory requirements for drugs, biologics, and medical devices in Europe, North America, and other world regions is our core focus.  [Xavier Luria, M.D.](https://www.veristat.com/company/scientific-leaders), is now the Vice President of Regulatory Affairs, Europe at Veristat.  He continues to lead the European regulatory team, which combined the Veristat and all of the DDR regulatory team members.   

We always have and will continue to deliver regulatory strategies and insights for success.  Meet Veristat.

[![LET'S TALK](https://no-cache.hubspot.com/cta/default/1333476/1231402d-00ae-4dfd-a737-10c3ee80a0a2.png)](https://cta-redirect.hubspot.com/cta/redirect/1333476/1231402d-00ae-4dfd-a737-10c3ee80a0a2)

<https://www.veristat.com/services/regulatory-affairs-overview>

[![full-service-01](https://www.veristat.com/hs-fs/hubfs/full-service-01.jpg?width=1324&height=884&name=full-service-01.jpg) 

](https://www.veristat.com/services/regulatory-affairs-overview)

## [Regulatory Expertise Regulatory expertise to guide you through the entire drug/device development and regulatory submission process to achieve regulatory success.  [**Learn more**](https://www.veristat.com/services/regulatory-affairs-overview)](https://www.veristat.com/services/regulatory-affairs-overview)

<https://www.veristat.com/services/full-service-solutions>

[![full-service-02](https://www.veristat.com/hs-fs/hubfs/full-service-02.jpg?width=600&height=401&name=full-service-02.jpg) 

](https://www.veristat.com/services/full-service-solutions)

## [Full Service Solutions Solutions to advance your novel medical therapies from Phase I-III clinical development to market with confidence. **[Learn more](https://www.veristat.com/services/full-service-solutions)**](https://www.veristat.com/services/full-service-solutions)

<https://www.veristat.com/services>

[![clinical-care](https://www.veristat.com/hs-fs/hubfs/clinical-care.jpg?width=600&height=401&name=clinical-care.jpg) 

](https://www.veristat.com/services)

## [Clinical Trial Services Bold thinking to solve all the difficult challenges throughout the development and regulatory approval process. [**Learn more**](https://www.veristat.com/services)](https://www.veristat.com/services)

#### Veristat teams supported marketing applications for 12% of all FDA Novel Drug Approvals in 2021.  [Learn More.](https://www.veristat.com/news/veristat-supported-marketing-applications-for-fda-2021)

 

 

[![Home Page_News Image_ART 2](https://www.veristat.com/hs-fs/hubfs/Home%20Page_News%20Image_ART%202.png?width=393&height=160&name=Home%20Page_News%20Image_ART%202.png)

## Listen to Our ART Podcast Series

Presented by the Center of Excellence for Cell & Gene Therapies

](https://cellandgene.expert/)

[![voyager-header-02](https://www.veristat.com/hs-fs/hubfs/voyager-header-02.jpg?width=500&height=230&name=voyager-header-02.jpg)

## Subscribe to our Newsletter

Get practical insights, best practices, and lessons-learned from our in-house experts in biometrics, operations, and regulatory affairs.

](https://info.veristat.com/latest-newsletter)

![social-media-header](https://www.veristat.com/hs-fs/hubfs/social-media-header.jpg?width=400&height=184&name=social-media-header.jpg)

## Follow Us on Social Media

[* *](https://www.linkedin.com/company/veristat-llc/) [* *](https://twitter.com/VeristatCRO) [* *](https://www.facebook.com/VeristatCRO)

[![Contact Us](https://no-cache.hubspot.com/cta/default/1333476/7b41f88a-70c5-40cc-8de7-c5404ac03e17.png)](https://cta-redirect.hubspot.com/cta/redirect/1333476/7b41f88a-70c5-40cc-8de7-c5404ac03e17)

[![Request A Proposal](https://no-cache.hubspot.com/cta/default/1333476/825bf82a-552b-48fc-93ca-0d970d57daa6.png)](https://cta-redirect.hubspot.com/cta/redirect/1333476/825bf82a-552b-48fc-93ca-0d970d57daa6)

### Get Updates

- [Privacy Policy](https://www.veristat.com/custom-privacy)
- ©2023 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.

- [** ](https://www.linkedin.com/company/veristat-llc)
- [** ](https://www.facebook.com/VeristatCRO)

![](https://px.ads.linkedin.com/collect/?pid=699986&fmt=gif)